Pricing
Prices are indicative MRP and may vary by pharmacy. Trend compares against the last recorded price.
সব দামের পরিবর্তন →ইঙ্গিত ও ব্যবহার
Ubilon এর জন্য নির্দেশিত:
ডোজ নির্দেশিকা
শুধুমাত্র নির্দেশিকা তথ্য
প্রদর্শিত ডোজগুলি সরকারি উৎসের সাধারণ নির্দেশিকা। ব্যক্তিগতকৃত ডোজের জন্য সর্বদা আপনার ডাক্তার বা ফার্মাসিস্টের পরামর্শ নিন।
Adults:
The dose is one Tibolone tablet per day, providing 2.5 mg daily. The tablet should be swallowed with some water or another drink, preferably at the same time each day. Improvement of symptoms generally occurs within a few weeks, but the best results are obtained when therapy is continued for at least 3 months. Starting Tibolone tablet: Women experiencing a natural menopause should begin treatment with Tibolone tablet at least 12 months after their last natural bleed. In the case of a surgical menopause, treatment with Tibolone tablet may begin immediately. Switching from a sequential or continuous combined HRT (hormone replacement therapy) preparation: If changing from a sequential HRT preparation, treatment with Tibolone should start the day after the prior regimen is completed. If changing from a continuous combined HRT preparation, treatment can start at any time. Missed dose: A missed dose should be taken as soon as it is remembered, unless it is more than 12 hours overdue. In that case, the missed dose should be skipped, and the next dose should be taken at the usual time. Missing a dose may increase the likelihood of breakthrough bleeding and spotting.
পার্শ্বপ্রতিক্রিয়া
Occasionally, some vaginal bleeding or spotting may occur, especially in the first few months of treatment. Other side effects reported include headache, migraine, swelling (oedema), dizziness, itching, weight gain, nausea, abdominal pain, skin rash, and depression.
সতর্কতা ও নিষেধাজ্ঞা
Warnings & Precautions
Should be used with caution in patients with kidney problems, a history of liver disease, epilepsy, migraine, high cholesterol, impaired carbohydrate (sugar) metabolism, diabetes, or a past episode of cholestatic jaundice.
নিষেধাজ্ঞা
Contraindicated in pregnancy and breastfeeding; in known or suspected hormone-dependent tumours; in cardiovascular or cerebrovascular disease; in active deep vein thrombosis or other thromboembolic disorders; in vaginal bleeding of unexplained cause; and in severe liver disease.